NEOG
NASDAQNeogen Corporation
Price$11.82-0.50 (-4.10%)
01:30 PM07:45 PM
News · 26 weeks44+467%
2026-04-192026-10-11
Mix3590d
- Insider17(49%)
- SEC Filings9(26%)
- Earnings3(9%)
- Other4(11%)
- Offering1(3%)
- Analyst1(3%)
Latest news
25 items- INSIDERSEC Form 4 filed by Neogen Corporation4 - NEOGEN CORP (0000711377) (Issuer)
- PRNeogen Outlines Strategy for Growth, Innovation and Margin Expansion at 2026 Investor DayCompany presented three pillars of value creation fueling its category leadership: commercial prowess, high-impact innovation and operational excellence Neogen Corporation (NASDAQ:NEOG) today hosted its 2026 Investor Day, "Shaping the Future of Food Safety," in New York City, where the company's senior leadership team outlined a comprehensive strategy for sustained profitable growth and category leadership, and provided a framework under which it plans to achieve financial targets by fiscal year 2031. The event featured presentations from Mike Nassif, President and Chief Executive Officer; Bryan Riggsbee, Chief Financial Officer; Dr. Tammi Ranalli, Senior Vice President and General Mana
- SECSEC Form 10-Q filed by Neogen Corporation10-Q - NEOGEN CORP (0000711377) (Filer)
- SECSEC Form 8-K filed by Neogen Corporation8-K - NEOGEN CORP (0000711377) (Filer)
- SECSEC Form 8-K filed by Neogen Corporation8-K - NEOGEN CORP (0000711377) (Filer)
- PRNeogen Reports First-Quarter Financial Results for Fiscal Year 2027Revenue of $222.8 million, representing growth of 6.5% and Core Growth1 of 8.1% Food Safety revenue growth of 7.4%, including Core Growth1 of 8.1% Animal Safety revenue growth of 4.2%, including Core Growth1 of 8.0% Net loss of $11.9 million with EPS of $(0.05); Adjusted Net Income1 of $17.5 million with Adjusted EPS1 of $0.08 Cash flow from operations of $12.9 million and free cash flow of $4.7 million Adjusted EBITDA1 of $41.6 million, with Adjusted EBITDA1 margin of 18.7% Company on track to manufacture saleable Petrifilm® product and begin planned multi-quarter manufacturing transition in November 2026; first single kit unit (SKU) fully validated Raising fiscal yea
- PRNeogen Announces Strategic Collaboration with Hinalea Imaging to Advance Digital Food Safety SolutionsCompanies to develop intelligent imaging solutions for food safetyNeogen® Corporation (NASDAQ:NEOG), a global leader in food safety solutions, is advancing its innovation strategy by combining deep food safety expertise with emerging technologies to introduce novel solutions to the Food Safety industry that address evolving customer challenges. As part of that strategy, Neogen today announced a strategic collaboration with and an equity investment in Hinalea Imaging Corp. to develop digital imaging solutions for food safety and quality inspection.Neogen and Hinalea have worked together since 2025 to evaluate applications for hyperspectral imaging in food safety. Building on that work, the co
- NEWSNEOG Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Neogen (NEOG)NEW YORK CITY, NY / ACCESS Newswire / October 5, 2026 / Multiple fungal species, identified through FDA testing in a Neogen Vet product marketed as sterile, drove Neogen Corporation (NASDAQ:NEOG) shares down 7.22%. If you bought NEOG and are now holding a loss, you have legal rights. Shareholders who lost money on Neogen are encouraged to submit their loss information now while the investigation is underway. You may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.The product at the center of the FDA action is HYCOAT, which Neogen sold under its Neogen Vet brand and which has since been recalled. Published reports linked HYCOAT to nearl
- INSIDERDirector Woteki Catherine E was granted 9,804 units of Restricted Stock Units, increasing direct ownership by 51% to 28,921 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERDirector Wainer Andrea F was granted 9,804 units of Restricted Stock Units, increasing direct ownership by 483% to 11,834 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERDirector Rodriguez Rafael A was granted 9,804 units of Restricted Stock Units, increasing direct ownership by 47% to 30,625 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERDirector Pelossof Avi was granted 9,804 units of Restricted Stock Units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERDirector Gupta Aashima was granted 9,804 units of Restricted Stock Units, increasing direct ownership by 35% to 37,594 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERDirector Green Ronald D was granted 9,804 units of Restricted Stock Units, increasing direct ownership by 53% to 28,458 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERDirector Capello Jeffrey D was granted 9,804 units of Restricted Stock Units, increasing direct ownership by 30% to 42,306 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERDirector Borel James C was granted 9,804 units of Restricted Stock Units, increasing direct ownership by 10% to 106,151 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- SECSEC Form DEFA14A filed by Neogen CorporationDEFA14A - NEOGEN CORP (0000711377) (Filer)
- PRNeogen Announces First-Quarter Earnings Release DateNeogen® Corporation (NASDAQ:NEOG) will issue its first-quarter earnings release after the closing of the market on October 6, 2026. Executives from the company will host a webcast and conference call beginning at 4:30 p.m. Eastern time, to discuss the financial results. The conference call can be accessed by dialing: Toll-Free - North America: 1-833-461-5787 International: (+1) 626-884-3620 Conference ID: 323 558 822 The live webcast can be accessed through Neogen’s Investor Relations webpage, neogen.com/investor-relations, under the "Events & Presentations" subheading. A replay of the conference call and webcast will be available shortly following the conclusion of the call and can b
- PRNeogen to Host Investor Day on October 7, 2026Neogen® Corporation (NASDAQ:NEOG) announced today that it will host an Investor Day on Wednesday, October 7, 2026, at 9 a.m. ET in New York City. The focus of the event will be on Neogen’s strategic transformation as the Company provides additional details on its commercial prowess, high-impact innovation, and operational excellence to drive sustainable improvement in financial performance. Mike Nassif, President and Chief Executive Officer; Bryan Riggsbee, Chief Financial Officer; Dr. Tammi Ranalli, Senior Vice President and General Manager, Global Food Safety; Joe Freels, Chief Commercial Officer; Jeremy Yarwood, Chief Scientific Officer; and Jim Walter, Senior Vice President, Manufactu
- ANALYSTNeogen upgraded by Piper Sandler with a new price targetPiper Sandler upgraded Neogen from Neutral to Overweight and set a new price target of $14.00
- SECSEC Form DEFA14A filed by Neogen CorporationDEFA14A - NEOGEN CORP (0000711377) (Filer)
- SECSEC Form DEF 14A filed by Neogen CorporationDEF 14A - NEOGEN CORP (0000711377) (Filer)
- INSIDERChief Accounting Officer Moylan John Patrick covered exercise/tax liability with 2,365 units of Restricted Stock Units, decreasing direct ownership by 7% to 29,331 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERCEO Nassif Mikheal covered exercise/tax liability with 20,397 units of Restricted Stock Units, decreasing direct ownership by 44% to 25,655 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
- INSIDERChief Accounting Officer Moylan John Patrick was granted 8,584 units of Restricted Stock Units, increasing direct ownership by 36% to 32,155 units (SEC Form 4)4 - NEOGEN CORP (0000711377) (Issuer)
NEOG FAQ
7 questionsWhat does Neogen Corporation do?
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid...Where does NEOG stock trade?
Neogen Corporation (NEOG) is listed on NASDAQ.What sector and industry is NEOG in?
Neogen Corporation operates in the Health Care sector, Biotechnology: In Vitro & In Vivo Diagnostic Substances industry.When did Neogen Corporation go public?
Neogen Corporation (NEOG) completed its IPO in 1989.What are analysts saying about NEOG?
Neogen Corporation has had 6 recent analyst actions on file. The most recent action was from Piper Sandler: Overweight with a $1400.00 price target on 2026-08-26. Recent price targets range from $1400.00 to $2500.00.What companies are similar to NEOG?
Notable peers in the same industry include IDXX (IDEXX Laboratories Inc.), LNTH (Lantheus Holdings Inc.), ORKA (Oruka Therapeutics Inc.), OCDX (Ortho Clinical Diagnostics Holdings plc), CLDX (Celldex Therapeutics Inc.). Compare NEOG side-by-side with any of them on Quantisnow.How can I track NEOG on Quantisnow?
Quantisnow aggregates Neogen Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NEOG to receive live email and push alerts on every new disclosure.